Related references
Note: Only part of the references are listed.Combination Strategies on the Basis of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?
Meng Qiao et al.
CLINICAL LUNG CANCER (2018)
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer
Carlo Genova et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer
Olga A. Timofeeva et al.
ONCOTARGET (2017)
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
Xuefeng Liu et al.
NATURE PROTOCOLS (2017)
Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts
Kristina A. Butler et al.
NEOPLASIA (2017)
Pharmacological Rescue of Conditionally Reprogrammed Cystic Fibrosis Bronchial Epithelial Cells
Martina Gentzsch et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering
Colin R. Butler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Management of non-small cell lung cancer in the era of personalized medicine
Gaetano Rocco et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers
Adi F. Gazdar et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Metastasis as an evolutionary process
Samra Turajlic et al.
SCIENCE (2016)
Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer
Yoon Young Choi et al.
SCIENTIFIC REPORTS (2016)
Resisting Resistance: Targeted Therapies in Lung Cancer
Jessica J. Lin et al.
TRENDS IN CANCER (2016)
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer
G. Sette et al.
CELL DEATH & DISEASE (2015)
Breaking the In Vitro Alveolar Type II Cell Proliferation Barrier while Retaining Ion Transport Properties
Peter F. Bove et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S. Crystal et al.
SCIENCE (2014)
Genotyping and Genomic Profiling of Non-Small-Cell Lung Cancer: Implications for Current and Future Therapies
Tianhong Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Xuefeng Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells
Frank A. Suprynowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Basal cells as stem cells of the mouse trachea and human airway epithelium
Jason R. Rock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification and expansion of the tumorigenic lung cancer stem cell population
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2008)
USE OF CAVEOLIN-1, THYROID TRANSCRIPTION FACTOR-1, AND CYTOKERATINS 7 AND 20 IN DISCRIMINATING BETWEEN PRIMARY AND SECONDARY PULMONARY ADENOCARCINOMA FROM BREAST OR COLONIC ORIGIN
Shu-Chuan Tsao et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)